[Gene therapy for hepatocellular carcinoma. From the idea to clinical trials].
Gerolami
R
R
INSERM U 559, Faculté de la Timone, Marseille, France.
Uch
R
R
Cardoso
J
J
Bagnis
C
C
Mannoni
P
P
Bréchot
C
C
D020533:Angiogenesis Inhibitors; D000818:Animals; D017209:Apoptosis / Q000235:genetics; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004195:Disease Models, Animal; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000628:therapy*; D016376:Oligonucleotides, Antisense; D018139:Simplexvirus / Q000201:enzymology; D013937:Thymidine Kinase / Q000235:genetics
D020533:Angiogenesis Inhibitors; D016376:Oligonucleotides, Antisense; D013937:Thymidine Kinase